ERCC3 and neoplasm: Although mB7-H3 expression was lower in CP341 PDXs than the ATM-loss CP50C PDX, the CP341 CRPC tumour also harboured pathogenic ATM and TP53 mutations as well as RB1 alteration and ERCC3 deletion (Fig. 4A, B).